12:00 AM
 | 
Jul 30, 2012
 |  BC Week In Review  |  Company News  |  Deals

Roche, Areva deal

Areva's Areva Med LLC (Bethesda, Md.) subsidiary partnered with Roche to create an alpha radio-immunotherapy platform to treat cancer. Roche's Pharma Research & Early Development organization (pRED) will assess the efficacy of combining Roche-engineered antibodies...

Read the full 162 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >